These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28099843)

  • 61. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia.
    Quiroga AD; Li L; Trötzmüller M; Nelson R; Proctor SD; Köfeler H; Lehner R
    Hepatology; 2012 Dec; 56(6):2188-98. PubMed ID: 22806626
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1.
    Li J; Wang Y; Matye DJ; Chavan H; Krishnamurthy P; Li F; Li T
    J Biol Chem; 2017 Jan; 292(1):146-160. PubMed ID: 27881673
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.
    Xiao D; Shi D; Yang D; Barthel B; Koch TH; Yan B
    Biochem Pharmacol; 2013 Feb; 85(3):439-47. PubMed ID: 23228697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
    Darkhal P; Gao M; Ma Y; Liu D
    Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Roles for Cell-Cell Adhesion and Contact in Obesity-Induced Hepatic Myeloid Cell Accumulation and Glucose Intolerance.
    Miyachi Y; Tsuchiya K; Komiya C; Shiba K; Shimazu N; Yamaguchi S; Deushi M; Osaka M; Inoue K; Sato Y; Matsumoto S; Kikuta J; Wake K; Yoshida M; Ishii M; Ogawa Y
    Cell Rep; 2017 Mar; 18(11):2766-2779. PubMed ID: 28297678
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver.
    Sharawy MH; El-Awady MS; Megahed N; Gameil NM
    Can J Physiol Pharmacol; 2016 May; 94(5):488-97. PubMed ID: 26871756
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice.
    Naowaboot J; Wannasiri S; Pannangpetch P
    J Physiol Biochem; 2016 Jun; 72(2):269-80. PubMed ID: 26976296
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prolyl hydroxylase domain protein 2 plays a critical role in diet-induced obesity and glucose intolerance.
    Matsuura H; Ichiki T; Inoue E; Nomura M; Miyazaki R; Hashimoto T; Ikeda J; Takayanagi R; Fong GH; Sunagawa K
    Circulation; 2013 May; 127(21):2078-87. PubMed ID: 23630130
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation.
    Hoy AJ; Bruce CR; Turpin SM; Morris AJ; Febbraio MA; Watt MJ
    Endocrinology; 2011 Jan; 152(1):48-58. PubMed ID: 21106876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in mice.
    Xie J; Shao Y; Liu J; Cui M; Xiao X; Gong J; Xue B; Zhang Q; Hu X; Duan H
    Sci Rep; 2020 Nov; 10(1):20038. PubMed ID: 33208918
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of a Caco-2 Cell Line Carrying the Human Intestine-Type CES Expression Profile as a Promising Tool for Ester-Containing Drug Permeability Studies.
    Ishizaki Y; Furihata T; Oyama Y; Ohura K; Imai T; Hosokawa M; Akita H; Chiba K
    Biol Pharm Bull; 2018; 41(5):697-706. PubMed ID: 29709907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.
    Gabriele M; Puccini P; Gervasi PG; Longo V
    Life Sci; 2021 Jul; 277():119486. PubMed ID: 33864822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activity and Expression of Carboxylesterases and Arylacetamide Deacetylase in Human Ocular Tissues.
    Hammid A; Fallon JK; Lassila T; Vieiro P; Balla A; Gonzalez F; Urtti A; Smith PC; Tolonen A; Honkakoski P
    Drug Metab Dispos; 2022 Dec; 50(12):1483-1492. PubMed ID: 36195336
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective detection of carboxylesterase 2 activity in cancer cells using an activity-based chemiluminescent probe.
    Ozsan C; Kailass K; Digby EM; Almammadov T; Beharry AA; Kolemen S
    Chem Commun (Camb); 2022 Sep; 58(78):10929-10932. PubMed ID: 36065979
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endoplasmic Reticulum Targeting Ratiometric Fluorescent Probe for Carboxylesterase 2 Detection in Drug-Induced Acute Liver Injury.
    Tian X; Yan F; Zheng J; Cui X; Feng L; Li S; Jin L; James TD; Ma X
    Anal Chem; 2019 Dec; 91(24):15840-15845. PubMed ID: 31713417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of pyrazolones as novel carboxylesterase 2 inhibitors that potently inhibit the adipogenesis in cells.
    Qian XK; Zhang J; Song PF; Zhao YS; Ma HY; Jin Q; Wang DD; Guan XQ; Li SY; Bao X; Zou LW
    Bioorg Med Chem; 2021 Jun; 40():116187. PubMed ID: 33965840
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A highly sensitive and selective enzyme activated fluorescent probe for in vivo profiling of carboxylesterase 2.
    Liu SY; Zou X; Guo Y; Gao X
    Anal Chim Acta; 2022 Aug; 1221():340126. PubMed ID: 35934362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intestine-Specific Overexpression of Carboxylesterase 2c Protects Mice From Diet-Induced Liver Steatosis and Obesity.
    Maresch LK; Benedikt P; Feiler U; Eder S; Zierler KA; Taschler U; Kolleritsch S; Eichmann TO; Schoiswohl G; Leopold C; Wieser BI; Lackner C; Rülicke T; van Klinken J; Kratky D; Moustafa T; Hoefler G; Haemmerle G
    Hepatol Commun; 2019 Feb; 3(2):227-245. PubMed ID: 30766961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.